Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2015-07-30 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
公司与倪利锋签署之附条件生效的股份认购合同
Capital/Financing Update Classification · 100% confidence The document is a detailed contract titled '附条件生效的股份认购合同' (Conditional Share Subscription Agreement) between a company and an individual for a non-public issuance of shares. It includes terms about share subscription, pricing, payment, obligations, legal compliance, and conditions for effectiveness. It is a legal contract related to a capital raising transaction, specifically a private placement of shares. There is no indication that this is a report, announcement of voting results, or a regulatory filing. The content fits the category of Capital/Financing Update (CAP) as it details the terms of a financing transaction involving share issuance.
2015-07-30 Chinese
复牌公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the resumption of trading (relisting) of the company's stock after a suspension due to a non-public stock issuance plan. It mentions the stock suspension date, board approval of the issuance, and the resumption date. The document is only 402 characters long and does not contain financial statements or detailed financial data. It is an official notice about stock trading status related to capital activity but does not provide detailed financing information itself. Given the content and length, it fits best as a Capital/Financing Update (CAP) rather than a full report or a simple report publication announcement.
2015-07-30 Chinese
2015年非公开发行股票预案
Capital/Financing Update Classification · 95% confidence The document is titled "2015 年非公开发行股票预案" which translates to "2015 Non-public Issuance of Shares Proposal". It details the plan for a non-public issuance of shares by Jiangsu Sihuan Bioengineering Co., Ltd. It includes information about the issuance background, purpose, pricing, number of shares, investors, and use of proceeds. The document is comprehensive and contains detailed financial and strategic information related to the capital raising activity. There is no indication that this is an announcement of a report or a certification. The content clearly relates to a capital/financing update regarding a non-public share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2015-07-30 Chinese
江苏晨薇生态园科技有限公司与江苏春辉生态农林股份有限公司签订之附生效条件的资产收购合同
M&A Activity Classification · 95% confidence The document is a detailed asset acquisition contract between two companies, specifying terms of the asset purchase, payment, delivery, warranties, liabilities, and legal provisions. It includes specific transaction details such as asset description, pricing, payment method, and conditions precedent. The document is a legal contract related to a merger/acquisition transaction rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, or management commentary. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including asset acquisition contracts.
2015-07-30 Chinese
公司与江苏德源纺织服饰有限公司签订之附生效条件的股权转让合同
M&A Activity Classification · 95% confidence The document is a detailed contract titled '附生效条件的股权转让合同' (Conditional Equity Transfer Agreement) between two companies, Jiangsu Sihuan Bio and Jiangsu Deyuan Textile. It outlines terms for a non-public issuance of shares and the purchase of 65% equity in a target company. The content includes transaction price, payment method, asset delivery, warranties, confidentiality, breach liabilities, and legal jurisdiction. There are no financial statements, audit opinions, earnings data, or regulatory certifications. The document is a legal contract related to a share transfer transaction, not a report or announcement of financial results or governance changes. It is not a merger proxy or tender offer form but a contractual agreement for equity transfer. Therefore, it fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids, including share transfer agreements with conditions.
2015-07-30 Chinese
2015年非公开发行股票募集资金使用可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is titled '2015年非公开发行股票 募集资金使用可行性分析报告' which translates to '2015 Non-public Stock Issuance Fundraising Feasibility Analysis Report'. It details the use of funds raised from a non-public stock issuance, including investment plans, project backgrounds, financial data of acquired companies, and strategic objectives. The content focuses on capital raising activities, investment projects, and the use of proceeds from the stock issuance. There is no indication that this is an annual report, earnings release, or other financial statement. Instead, it is a detailed update on capital raising and financing activities related to a non-public stock issuance. Therefore, the document fits best under the category 'Capital/Financing Update' (CAP). The document length is substantial and contains detailed financial and project information related to financing, supporting a high confidence classification.
2015-07-30 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.